Rep. Gerry Connolly Dies at 75; Biden Reveals Advanced Prostate Cancer Diagnosis

Congressman Gerald E. “Gerry” Connolly, a longtime Democratic representative from Virginia and the ranking member of the House Oversight Committee, passed away peacefully at his home Wednesday morning. He was 75.

In a statement released by his family, Connolly was remembered as a dedicated public servant, deeply committed to his constituents and to justice. “It is with immense sadness that we share that our devoted and loving father, husband, brother, friend, and public servant, Congressman Gerald E. Connolly, passed away peacefully at his home this morning surrounded by family,” the statement read.

“Gerry lived his life to give back to others and make our community better,” his family continued. “He looked out for the disadvantaged and voiceless. He always stood up for what is right and just. His absence will leave a hole in our hearts, but we are proud that his life’s work will endure for future generations. We thank you for your love of Gerry, and know he loved you all so much.”

Connolly had recently announced that he would not seek reelection and would step away from his leadership role on the powerful House Oversight Committee. That decision came following news that his esophageal cancer, originally disclosed in November, had returned.

A fixture in Northern Virginia politics for decades, Connolly served Fairfax County before winning a seat in Congress in 2008. Throughout his career, he was known for his sharp wit, principled stands, and fierce advocacy on issues ranging from civil rights to government transparency. His legislative record reflected a deep concern for workers’ rights, climate change, and support for diplomatic efforts overseas.

As the nation mourns the passing of one of its committed lawmakers, another political figure has been thrust into the spotlight over his own health concerns.

Former President Joe Biden revealed last week that he has been diagnosed with advanced prostate cancer, characterized by a Gleason score of 9—indicating a highly aggressive form of the disease. The cancer has reportedly metastasized to his bones.

The diagnosis came after Biden experienced increasing urinary symptoms and underwent further medical examination. According to his team, the cancer is classified as “hormone-sensitive,” a factor that may allow for more effective treatment options through hormone therapy. Biden and his family are currently consulting with his physicians to determine the best course of action.

A spokesperson confirmed that Biden had not been previously diagnosed with prostate cancer and that his last known prostate-specific antigen (PSA) test was in 2014. This long gap between screenings has raised questions about the timing and transparency of his medical care. Some observers are expressing concern over how the condition may have gone undetected for so long, despite Biden having undergone multiple physical examinations in recent years.

The PSA test, a standard screening tool used to detect prostate issues, measures levels of prostate-specific antigen in the blood. Elevated PSA levels can indicate cancer, but they may also be caused by non-cancerous conditions such as an enlarged or inflamed prostate. The Mayo Clinic notes that interpreting PSA results can be complex, as various benign factors can influence the outcome.

The aggressive nature of Biden’s cancer, indicated by the high Gleason score and evidence of metastasis, has intensified scrutiny over his health status—particularly as it follows recent reports and books alleging that key members of his staff may have downplayed his declining physical and cognitive health during his presidency.

Former President Donald Trump weighed in on the issue, questioning the lack of earlier detection and transparency. “There are things going on that the public wasn’t informed of,” Trump said. “This is no longer politically correct. This is dangerous for our country. Somebody is not telling the facts.”

The announcement of Biden’s diagnosis comes amid a politically charged environment, where concerns about the age and health of national leaders have become central to public discourse. With the 2024 election in the rearview mirror and Biden now a former president, this revelation will likely fuel debate about how candidates’ health should be monitored and disclosed to the American people.

As both the public and political circles process the death of Rep. Connolly and the serious health condition of President Biden, the news underscores the human side of public service—a reminder that even those in power are not immune to life’s frailties.